AI-Driven Telehealth Platform
Proprietary AI-driven platform with risk stratification, predictive analytics, and medication risk management
Company profile
Company profile
PharmD Live provides a focused care delivery model designed explicitly for high-risk, high-cost patients with chronic diseases. The company combines a clinical pharmacist-led approach with AI-driven telehealth technology and predictive analytics to deliver comprehensive chronic care management solutions. Their platform addresses critical healthcare challenges including adverse drug events (the 4th leading cause of death in the US), medication non-adherence (affecting 50% of prescriptions), and physician burnout. PharmD Live offers a suite of telehealth services including Chronic Care Management, Remote Patient Monitoring, Medication Therapy Management, Transitional Care Management, Annual Wellness Visits, Pharmacogenomics, Diabetes Prevention Programs, and Medication Adherence Programs. The company serves physicians, hospitals and health systems, ACOs/IDNs, healthcare payers, pharmaceutical companies, and post-acute care facilities. Their proprietary technology platform seamlessly integrates with existing EHR systems and provides advanced insights, risk stratification, and medication risk management algorithms. PharmD Live's 24/7 nationwide network of board-certified clinical pharmacists handles patient encounters, alleviating provider workload while improving MIPS, APMs, HEDIS, and other CMS quality measures. The company's solutions are designed to close care gaps, reduce hospital readmissions, prevent adverse drug events, and maximize value-based care profitability across healthcare verticals.
Company description PharmD Live official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: EHR systems (most major systems mentioned but not specifically named).
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Proprietary AI-driven platform with risk stratification, predictive analytics, and medication risk management
Optimize patient health through health risk assessments and personalized disease prevention plans
Outcome-driven and evidence-based chronic care management solution for patients with multiple chronic conditions
Evidence-based interventions to prevent type 2 diabetes and mitigate prediabetes conditions
Advanced analytics and pharmacological expertise to prevent adverse drug events through adherence monitoring
Reducing adverse drug events through comprehensive medication therapy management
Identifying drug therapy responders and non-responders to guide individualized treatment plans
Best in class devices capturing patient-generated health data and driving quality, clinical and economic outcomes
Supporting patients during care transitions to reduce hospital readmissions
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
When MIPS and APM scores are improved through RPM
Patients report increased engagement, satisfaction and loyalty with RPM
Through Transitional Care Management and chronic care coordination
Through medication management and adherence monitoring
Patient benefits from CCM program
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on PharmD Live's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.